These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 16783132)
1. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users. Rodríguez Salgado D; Rodríguez Alvarez M; Seoane Pesqueira G Cogn Behav Neurol; 2006 Jun; 19(2):95-104. PubMed ID: 16783132 [TBL] [Abstract][Full Text] [Related]
2. [HIV prevention in HIV-positive drug addicts. A methadone-supported model]. Oertle D; Edelmann R; Ostewalder J; Vernazza PL; Galeazzi RL Schweiz Med Wochenschr; 1993 Dec; 123(48):2284-92. PubMed ID: 8272803 [TBL] [Abstract][Full Text] [Related]
3. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy. Avants SK; Margolin A; Usubiaga MH; Doebrick C J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083 [TBL] [Abstract][Full Text] [Related]
4. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs. Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416 [TBL] [Abstract][Full Text] [Related]
5. Neuropsychological impairment and the natural history of HIV-1 infection in Spanish subjects. Rodríguez Alvarez M; Faílde Garrido JM; Simón López MA Funct Neurol; 2007; 22(3):165-70. PubMed ID: 17925167 [TBL] [Abstract][Full Text] [Related]
6. Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989. Robert CF; Déglon JJ; Wintsch J; Martin JL; Perrin L; Bourquin M; Gabriel V; Hirschel B AIDS; 1990 Jul; 4(7):657-60. PubMed ID: 2397058 [TBL] [Abstract][Full Text] [Related]
7. Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug users. Boccellari AA; Chambers DB; Dilley JW; Shore MD; Tauber MA; Moss AR; Osmond DH J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1040-9. PubMed ID: 7916050 [TBL] [Abstract][Full Text] [Related]
8. [Neuropsychological performance in patients with human inmunodeficiency (HIV) and hepatitis C virus (HCV) coinfection]. Failde Garrido JM; Rodríguez Alvarez M; López Castro J; Simón López MA Neurologia; 2009 Apr; 24(3):154-9. PubMed ID: 19418290 [TBL] [Abstract][Full Text] [Related]
9. Sexual behaviors and HIV infection in intravenous drug users in New York City. Banks SE; Brown LS; Ajuluchukwu D J Addict Dis; 1991; 10(3):15-23. PubMed ID: 1932149 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the prevalence of HIV infection in prison inmates at the time of their imprisonment during the period 1991-1995]. Martín Sánchez V; Caylá Buqueras JA; González Morís ML; Herrero Alonso LE; Vicente Pérez R Rev Esp Salud Publica; 1997; 71(3):269-80. PubMed ID: 9445755 [TBL] [Abstract][Full Text] [Related]
11. HIV infection as a predictor of methadone maintenance outcomes in Chinese injection drug users. Zhao L; Holzemer WL; Johnson M; Tulsky JP; Rose CD AIDS Care; 2012; 24(2):195-203. PubMed ID: 21780984 [TBL] [Abstract][Full Text] [Related]
12. [Prevalence of HIV-1 infection in intravenous drug dependent patients 1986 to 1989 in Vienna]. Loimer N; Presslich O; Hollerer E; Werner E; Pakesch G; Pfersmann V; Schmid-Siegel B; Aschauer G Wien Klin Wochenschr; 1990 Feb; 102(4):106-10. PubMed ID: 2316224 [TBL] [Abstract][Full Text] [Related]
13. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. Cherner M; Ellis RJ; Lazzaretto D; Young C; Mindt MR; Atkinson JH; Grant I; Heaton RK; AIDS; 2004 Jan; 18 Suppl 1():S27-34. PubMed ID: 15075495 [TBL] [Abstract][Full Text] [Related]
14. Mode of HIV transmission among seroconverted intravenous drug users (IVDUs): 1987 and 1988 cohort study. Nemoto T; Brown LS; Primm BJ; Foster K; Chu A NIDA Res Monogr; 1989; 95():407-8. PubMed ID: 2641011 [No Abstract] [Full Text] [Related]
15. Personal social networks and HIV status among women on methadone. el-Bassel N; Cooper DK; Chen DR; Schilling RF AIDS Care; 1998 Dec; 10(6):735-49. PubMed ID: 9924528 [TBL] [Abstract][Full Text] [Related]
16. Dyadic HIV status and psychological distress among women on methadone. Wu E; El-Bassel N; Gilbert L; Morse P Womens Health Issues; 2006; 16(3):113-21. PubMed ID: 16765287 [TBL] [Abstract][Full Text] [Related]
17. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects. Di Franco MJ; Marlink R; Hunter DJ; Tosteson T; Mayer K; Essex M J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1297-300. PubMed ID: 8254465 [TBL] [Abstract][Full Text] [Related]
18. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Relationship to head injury. Marder K; Stern Y; Malouf R; Tang MX; Bell K; Dooneief G; el-Sadr W; Goldstein S; Gorman J; Richards M Arch Neurol; 1992 Nov; 49(11):1169-75. PubMed ID: 1444884 [TBL] [Abstract][Full Text] [Related]
19. Behavioral risk factors of human immunodeficiency virus infection among intravenous drug users and implications for preventive interventions. Nemoto T; Brown LS; Foster K; Chu A AIDS Educ Prev; 1990; 2(2):116-26. PubMed ID: 2393617 [TBL] [Abstract][Full Text] [Related]
20. Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users' emergency department use and hospitalization. Turner BJ; Laine C; Yang CP; Hauck WW Clin Infect Dis; 2003 Dec; 37 Suppl 5():S457-63. PubMed ID: 14648464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]